<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="672">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04471766</url>
  </required_header>
  <id_info>
    <org_study_id>BHP MASK01</org_study_id>
    <nct_id>NCT04471766</nct_id>
  </id_info>
  <brief_title>Locally Produced Cloth Face Mask and COVID-19 Like Illness Prevention</brief_title>
  <official_title>Evaluation of Locally Produced Cloth Face Mask on COVID-19 and Respiratory Illnesses Prevention at the Community Level - a Cluster-randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bandim Health Project</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Southern Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Engineers without Borders, Denmark (https://iug.dk/en)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Bandim Health Project</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The number of cases of COVID-19 is still increasing and transmission of SARS-CoV-2 seems to&#xD;
      occur mainly through person-to-person transmission through respiratory droplets, indirect&#xD;
      contact with infected people and surfaces. The use of face masks is recommended as a public&#xD;
      health measure, but in many settings only domestic cloth made masks are available to the&#xD;
      majority of the people. However, masks can be of different quality and very little is known&#xD;
      about the utility of cloth face masks at the community level.&#xD;
&#xD;
      In Bandim Health Project's Health and Demographic Surveillance System we will evaluate the&#xD;
      effect of providing locally produced cloth face masks on severity of COVID-19 like illness&#xD;
      and mortality in an urban population. The locally produced cloth mask is made according to a&#xD;
      laboratory certified model and will be provided to the intervention group alongside&#xD;
      information of how the risk of transmission can be reduced. The control group will receive&#xD;
      information alone.&#xD;
&#xD;
      Follow-up will be implemented through telephone calls and post-epidemic home visits.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">July 20, 2020</start_date>
  <completion_date type="Anticipated">August 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reported COVID-like illness</measure>
    <time_frame>Four months follow-up</time_frame>
    <description>Self-reported main symptoms of COVID-19 (three or more - fever, cough, fatigue, shortness of breath, loss of smell / taste)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Consultation</measure>
    <time_frame>Four months follow-up</time_frame>
    <description>Consultation for COVID-19 like illness or/and reported positive test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Severe illness</measure>
    <time_frame>Four months follow-up</time_frame>
    <description>Self reported COVID-19 like illness plus hospitalization or death</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>Four months follow-up</time_frame>
    <description>Any death during the follow-up period</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40000</enrollment>
  <condition>COVID-19</condition>
  <condition>Respiratory Illness</condition>
  <arm_group>
    <arm_group_label>Certified cloth face mask plus preventive information</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Certified cloth face mask</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Information on COVID-19 prevention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Advice on how to prevent COVID-19 according to the government´ policy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Certified cloth face mask plus preventive information</intervention_name>
    <description>Provision of two face masks sewed locally following a certified model tested for FORCE in the laboratory per residents &gt; 10 years old</description>
    <arm_group_label>Certified cloth face mask plus preventive information</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Preventive information</intervention_name>
    <description>Advice on how to prevent COVID-19 according to the government´ policy</description>
    <arm_group_label>Certified cloth face mask plus preventive information</arm_group_label>
    <arm_group_label>Information on COVID-19 prevention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Household resident&#xD;
&#xD;
          -  Age: 10 years and older&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Refusal to participate&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Bandim Health Project</name>
      <address>
        <city>Bissau</city>
        <state>Bissau Codex</state>
        <country>Guinea-Bissau</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Guinea-Bissau</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>July 14, 2020</study_first_submitted>
  <study_first_submitted_qc>July 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 15, 2020</study_first_posted>
  <last_update_submitted>December 21, 2020</last_update_submitted>
  <last_update_submitted_qc>December 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Face mask</keyword>
  <keyword>COVID-19</keyword>
  <keyword>Respiratory illness</keyword>
  <keyword>Mortality</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

